Ganga Pharmaceuticals appointed M/s. D Maurya & Associates as Secretarial Auditor for FY 2026-27.
The appointment was approved by the Board on May 21, 2026, based on the Audit Committee's recommendation.
The disclosure is made pursuant to SEBI Listing Regulations Regulation 30 and a specific January 2026 circular.